Author:
Knoebel Randall W.,Dickerson David M.
Publisher
Springer International Publishing
Reference19 articles.
1. Gaertner J, Voltz R, Ostgathe C. Methadone: a closer look at the controversy. J Pain Symptom Manag. 2008;36(2):e4–6.
2. Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain. 1986;25:297–312.
3. Bruera E, Sweeney C. Methadone use in cancer patients: a review. J Palliat Med. 2002;5(1):127–38.
4. Ettinger DS, Vitale PJ, Trump DL. Important clinical pharmacologic considerations in the use of methadone in cancer patients. Cancer Treat Rep. 1979;63:457–9.
5. Garrido MJ, Aguirre C, Troconiz IF, et al. Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome. Int J Clin Pharmacol Ther. 2000;38(1):35–40.